J. Smolen, D. Aletaha, and I. Mcinnes, Rheumatoid arthritis, The Lancet, vol.388, issue.10055, pp.140-673630173, 2016.
DOI : 10.1016/S0140-6736(16)30173-8

URL : https://hal.archives-ouvertes.fr/hal-01256050

M. Innes, I. Schett, and G. , The pathogenesis of rheumatoid arthritis, N Engl J Med, vol.365, pp.2205-2224, 2011.

A. Finnegan, S. Ashaye, and K. Hamel, B effector cells in rheumatoid arthritis and experimental arthritis, Autoimmunity, vol.32, issue.10, pp.353-63, 2012.
DOI : 10.1136/ard.2008.092791

D. Aletaha, T. Neogi, A. Silman, J. Funovits, D. Felson et al., 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Annals of the Rheumatic Diseases, vol.69, issue.9, pp.1580-1588, 2010.
DOI : 10.1136/ard.2010.138461

J. Singh, D. Furst, A. Bharat, J. Curtis, A. Kavanaugh et al., 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis, Arthritis Care & Research, vol.42, issue.Suppl, pp.625-664, 2008.
DOI : 10.1002/acr.21641

J. Smolen, R. Landewé, F. Breedveld, M. Buch, G. Burmester et al., EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update, Annals of the Rheumatic Diseases, vol.69, issue.(Suppl), pp.492-509, 2014.
DOI : 10.1136/annrheumdis-2013-204573

M. Stoff-er, M. Schoels, and J. Smolen, Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update, Annals of the Rheumatic Diseases, vol.66, issue.1, pp.16-22, 2016.
DOI : 10.1136/annrheumdis-2015-207526

C. Daïen and J. Morel, Predictive Factors of Response to Biological Disease Modifying Antirheumatic Drugs: Towards Personalized Medicine, Mediators of Inflammation, vol.31, issue.2, p.386148, 2014.
DOI : 10.3899/jrheum.091176

M. Boissier, E. Assier, J. Biton, A. Denys, G. Falgarone et al., Regulatory T cells (Treg) in rheumatoid arthritis, Joint Bone Spine, vol.76, issue.1, pp.10-14, 2009.
DOI : 10.1016/j.jbspin.2008.08.002

S. Sakaguchi, N. Sakaguchi, and M. Asano, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, J Immunol, vol.155, pp.1151-64, 1995.

M. Morgan, R. Sutmuller, and H. Witteveen, CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis, Arthritis & Rheumatism, vol.39, issue.5, pp.1452-60, 2003.
DOI : 10.1002/art.11063

M. Morgan, R. Flierman, and L. Van-duivenvoorde, Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells, Arthritis & Rheumatism, vol.104, issue.7, pp.2212-2233, 2005.
DOI : 10.1002/art.21195

L. Nguyen, J. Jacobs, and D. Mathis, Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis, Arthritis & Rheumatism, vol.5, issue.2, pp.509-529, 2007.
DOI : 10.1002/art.22272

C. Lawson, A. Brown, and V. Bejarano, Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood, Rheumatology, vol.45, issue.10, pp.1210-1217, 2006.
DOI : 10.1093/rheumatology/kel089

J. Van-amelsfort, K. Jacobs, and J. Bijlsma, CD4+CD25+ regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluid, Arthritis & Rheumatism, vol.159, issue.9, pp.2775-85, 2004.
DOI : 10.1002/art.20499

M. Mottonen, J. Heikkinen, and L. Mustonen, CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis, Clinical and Experimental Immunology, vol.177, issue.2, pp.360-367, 2005.
DOI : 10.1038/ni846

D. Cao, R. Van-vollenhoven, and L. Klareskog, CD25brightCD4+ regulatory T-cells are enriched in inflamed joints of patients with chronic rheumatic disease, Arthritis Research & Therapy, vol.6, issue.4, pp.335-381, 2004.
DOI : 10.1186/ar1192

D. Kleer, I. Wedderburn, L. Taams, and L. , CD4+CD25bright Regulatory T Cells Actively Regulate Inflammation in the Joints of Patients with the Remitting Form of Juvenile Idiopathic Arthritis, The Journal of Immunology, vol.172, issue.10, pp.6435-6478, 2004.
DOI : 10.4049/jimmunol.172.10.6435

M. Ehrenstein, J. Evans, and A. Singh, Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNF?? Therapy, The Journal of Experimental Medicine, vol.155, issue.3, pp.277-85, 2004.
DOI : 10.1186/ar414

F. Ponchel, V. Goëb, R. Parmar, Y. El-sherbiny, M. Boissinot et al., An immunological biomarker to predict MTX response in early RA, Annals of the Rheumatic Diseases, vol.64, issue.(Suppl3), pp.2047-53, 2014.
DOI : 10.1136/annrheumdis-2013-203566

B. Saleem, H. Keen, V. Goeb, R. Parmar, S. Nizam et al., Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?, Annals of the Rheumatic Diseases, vol.69, issue.9, pp.1636-1678, 2010.
DOI : 10.1136/ard.2009.117341

M. Bonelli, L. Göschl, S. Blüml, T. Karonitsch, K. Hirahara et al., Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis, Rheumatology, vol.55, issue.4, pp.710-730, 2016.
DOI : 10.1093/rheumatology/kev403

L. Harrington, R. Hatton, P. Mangan, H. Turner, T. Murphy et al., Interleukin 17???producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, Nature Immunology, vol.173, issue.11, pp.1123-1155, 2005.
DOI : 10.1016/S1074-7613(00)80470-7

H. Park, Z. Li, X. Yang, S. Chang, R. Nurieva et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17, Nature Immunology, vol.103, issue.11, pp.1133-1174, 2005.
DOI : 10.1038/35051100

M. Sundrud and C. Trivigno, Identity crisis of Th17 cells: Many forms, many functions, many questions, Seminars in Immunology, vol.25, issue.4, pp.263-72, 2013.
DOI : 10.1016/j.smim.2013.10.021

E. Calderón-gómez, H. Bassolas-molina, R. Mora-buch, I. Dotti, N. Planell et al., Commensal-Specific CD4+ Cells From Patients With Crohn???s Disease Have a T-Helper 17 Inflammatory Profile, Gastroenterology, vol.151, issue.3, pp.16-508534576, 2016.
DOI : 10.1053/j.gastro.2016.05.050

C. Langrish, Y. Chen, and W. Blumenschein, IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, The Journal of Experimental Medicine, vol.71, issue.2, pp.233-273, 2005.
DOI : 10.1038/nri802

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212798

E. Lubberts, IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis?, Cytokine, vol.41, issue.2, pp.84-91, 2008.
DOI : 10.1016/j.cyto.2007.09.014

E. Acosta-rodriguez, L. Rivino, and J. Geginat, Surface phenotype and antigenic specificity of human interleukin 17???producing T helper memory cells, Nature Immunology, vol.179, issue.6, pp.639-685, 2007.
DOI : 10.1038/ni1467

W. Sato, T. Aranami, and T. Yamamura, Cutting Edge: Human Th17 Cells Are Identified as Bearing CCR2+CCR5- Phenotype, The Journal of Immunology, vol.178, issue.12, pp.7525-7534, 2007.
DOI : 10.4049/jimmunol.178.12.7525

C. Murphy, C. Langrish, Y. Chen, W. Blumenschein, T. Mcclanahan et al., Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation, The Journal of Experimental Medicine, vol.161, issue.12, pp.1951-1958, 2003.
DOI : 10.4049/jimmunol.168.11.5699

L. Tesmer, S. Lundy, S. Sarkar, and D. Fox, Th17 cells in human disease, Immunological Reviews, vol.29, issue.(Suppl.), pp.87-113, 2008.
DOI : 10.1111/j.1600-065X.2008.00628.x

E. Lubberts, M. Koenders, B. Oppers-walgreen, L. Van-den-bersselaar, C. Roo et al., Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion, Arthritis & Rheumatism, vol.9, issue.2, pp.650-659, 2004.
DOI : 10.1002/art.20001

M. Chabaud, J. Durand, N. Buchs, F. Fossiez, G. Page et al., Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium, Arthritis & Rheumatism, vol.177, issue.5, pp.963-70, 1999.
DOI : 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E

D. Furst and P. Emery, Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets, Rheumatology, vol.53, issue.9, pp.1560-1569, 2014.
DOI : 10.1093/rheumatology/ket414

N. Komatsu, K. Okamoto, and S. Sawa, Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis, Nature Medicine, vol.20, issue.1, pp.62-70, 2014.
DOI : 10.1016/S1534-5807(02)00369-6

S. Kotake, Y. Nanke, T. Yago, M. Kawamoto, T. Kobashigawa et al., ???Th17 Cells??? in Memory Th Cells Is Inversely Correlated with the Titer of Anti-CCP Antibodies in Early-Onset Rheumatoid Arthritis Patients Based on Flow Cytometry Methods of the Human Immunology Project, BioMed Research International, vol.155, issue.12, p.9694289, 2016.
DOI : 10.1093/rheumatology/keq224

S. Kotake, Y. Nanke, T. Yago, M. Kawamoto, T. Kobashigawa et al., Th17 Cells in Peripheral Blood of Early-Onset Rheumatoid Arthritis Patients, BioMed Research International, vol.155, issue.12, p.418602, 2016.
DOI : 10.1038/nrrheum.2014.183

R. Talotta, A. Berzi, F. Atzeni, A. Batticciotto, M. Clerici et al., Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response, Journal of Clinical Immunology, vol.20, issue.33, pp.550-557, 2015.
DOI : 10.1007/s10875-015-0182-0

L. Klareskog, K. Amara, and V. Malmström, Adaptive immunity in rheumatoid arthritis, Current Opinion in Rheumatology, vol.26, issue.1, pp.72-81, 2014.
DOI : 10.1097/BOR.0000000000000016

J. Berthelot, C. Jamin, K. Amrouche, L. Goff, B. Maugars et al., Regulatory B cells play a key role in immune system balance, Joint Bone Spine, vol.80, issue.1, pp.18-22, 2013.
DOI : 10.1016/j.jbspin.2012.04.010

URL : https://hal.archives-ouvertes.fr/hal-00771025

C. Mauri and A. Bosma, Immune Regulatory Function of B Cells, Annual Review of Immunology, vol.30, issue.1, pp.221-262, 2012.
DOI : 10.1146/annurev-immunol-020711-074934

O. Garraud, G. Borhis, G. Badr, S. Degrelle, B. Pozzetto et al., Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond, BMC Immunology, vol.13, issue.1, p.63, 2012.
DOI : 10.1172/JCI43271

URL : https://hal.archives-ouvertes.fr/inserm-00768593

R. Neta and S. Salvin, Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity, J. Immunol, vol.113, pp.1716-1741, 1974.

E. Rosser, P. Blair, and C. Mauri, Cellular targets of regulatory B cell-mediated suppression, Molecular Immunology, vol.62, issue.2, pp.296-304, 2014.
DOI : 10.1016/j.molimm.2014.01.014

I. Kalampokis, A. Yoshizaki, and T. Tedder, IL-10-producing regulatory B cells (B10 cells) in autoimmune disease, Arthritis Research & Therapy, vol.15, issue.Suppl 1, p.1, 2013.
DOI : 10.1002/eji.201041041

A. Bosma, A. Gadir, D. Isenberg, E. Jury, and C. Mauri, Lipid-Antigen Presentation by CD1d+ B Cells Is Essential for the Maintenance of Invariant Natural Killer T Cells, Immunity, vol.36, issue.3, pp.477-90, 2012.
DOI : 10.1016/j.immuni.2012.02.008

Y. Iwata, T. Matsushita, M. Horikawa, D. Dilillo, K. Yanaba et al., Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells, Blood, vol.117, issue.2, pp.530-571, 2011.
DOI : 10.1182/blood-2010-07-294249

P. Blair, L. Noreña, and F. Flores-borja, CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients, Immunity, vol.32, issue.1, pp.129-169, 2010.
DOI : 10.1016/j.immuni.2009.11.009

F. Flores-borja, A. Bosma, D. Ng, V. Reddy, M. Ehrenstein et al., CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation, Science Translational Medicine, vol.5, issue.173, pp.173-196, 2013.
DOI : 10.1126/scitranslmed.3005407

L. Ma, B. Liu, Z. Jiang, and Y. Jiang, Reduced numbers of regulatory B cells are negatively correlated with disease activity in patients with new-onset rheumatoid arthritis, Clinical Rheumatology, vol.6, issue.5, pp.187-95, 2014.
DOI : 10.1007/s10067-013-2359-3

C. Daien, S. Gailhac, T. Mura, R. A. Combe, B. Hahne et al., Regulatory B10 Cells Are Decreased in Patients With Rheumatoid Arthritis and Are Inversely Correlated With Disease Activity, Arthritis & Rheumatology, vol.33, issue.Suppl 39, pp.2037-2083, 2014.
DOI : 10.1002/art.38666

E. C. Rosser, Regulatory B Cells: Origin, Phenotype, and Function, Immunity, vol.42, issue.4, pp.607-612, 2015.
DOI : 10.1016/j.immuni.2015.04.005

J. Bouaziz, S. Calbo, and M. Maho-vaillant, IL-10 produced by activated human B cells regulates CD4+ T-cell activation in vitro, European Journal of Immunology, vol.40, issue.10, pp.2686-91, 2010.
DOI : 10.1002/eji.201040673

F. Sun, S. Ladha, L. Yang, Q. Liu, S. Shi et al., Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis, Muscle & Nerve, vol.48, issue.202, pp.487-94, 2014.
DOI : 10.1002/mus.23951

N. Colliou, D. Picard, F. Caillot, S. Calbo, L. Corre et al., Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response, Science Translational Medicine, vol.5, issue.175, pp.175-205, 2013.
DOI : 10.1126/scitranslmed.3005166

D. Bunch, J. Mcgregor, N. Khandoobhai, L. Aybar, and M. Burkart, Decreased CD5+ B Cells in Active ANCA Vasculitis and Relapse after Rituximab, Clinical Journal of the American Society of Nephrology, vol.8, issue.3, pp.382-91, 2013.
DOI : 10.2215/CJN.03950412

P. Roll, A. Palanichamy, C. Kneitz, T. Dorner, and H. Tony, Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis, Arthritis & Rheumatism, vol.174, issue.8, pp.2377-86, 2006.
DOI : 10.1002/art.22019

A. Alunno, M. Manetti, S. Caterbi, L. Ibba-manneschi, O. Bistoni et al., Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications, Mediators of Inflammation, vol.9, issue.8, 2015.
DOI : 10.1038/nrrheum.2014.105

F. Forger, N. Marcoli, and S. Gadola, Pregnancy induces numerical and functional changes of CD4+CD25high regulatory T cells in patients with rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.67, issue.7, pp.984-90, 2008.
DOI : 10.1136/ard.2007.075283

M. Boissier, E. Assier, and G. Falgarone, Shifting the imbalance from Th1/Th2 to Th17/treg: The changing rheumatoid arthritis paradigm, Joint Bone Spine, vol.75, issue.4, pp.373-378, 2008.
DOI : 10.1016/j.jbspin.2008.04.005

M. Genovese, P. Durez, H. Richards, J. Supronik, E. Dokoupilova et al., Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study, Annals of the Rheumatic Diseases, vol.72, issue.6
DOI : 10.1136/annrheumdis-2012-201601

P. Gazeau, V. Devauchelle-pensec, P. Pochard, J. Pers, A. Saraux et al., Abatacept efficacy in rheumatoid arthritis is dependent upon baseline blood B-cell levels, Rheumatology, vol.55, issue.6, pp.1138-1178, 2016.
DOI : 10.1093/rheumatology/kev417

URL : https://hal.archives-ouvertes.fr/hal-01270019